Sign in
Stories
Adicet Bio Awards Stock Options
Share
Advancements in Gene Editing and Cancer ...
Antibe's Receivership and Delisting
Arcus Biosciences Boosts Inducement Gran...
Acquisition Progress Amid Safety Concern
Adicet Bio Grants Inducement Stock Optio...
Arcus Biosciences Announces New Employme...
Overview
API
Adicet Bio granted an inducement award to a new hire, comprising 7,000 stock options under Nasdaq Listing Rule 5635(c)(4). The vesting schedule spans four years, with gradual vesting over time.
Ask a question
How does Adicet Bio's focus on allogeneic gamma delta T cell therapies position them in the competitive biotech landscape?
How might this inducement grant impact the recruitment and retention of skilled professionals in biotechnology?
What potential benefits and risks could be associated with utilizing inducement awards outside of approved equity plans?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage